Bodini, G. et al. Therapeutic Drug Monitoring in Crohn's Disease Patients, A Comparison Between Homogenous Mobility Shift Assay and Point of Care Method. UEGW 2019, Feb 09 – 11, 2018. Barcelona, Spain. P1750. Read Citation BÜHLMANN Quantum Blue® Infliximab is for Research Use Only in the US. Not for use in diagnostic procedures in the US. Health
Continue Reading
- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites